''Biotech, domestic healthcare manufacturing and food staples will still have export demand and so the market will naturally favour these. ''
Are you serious Kickst@rter
Do you honestly think the market will favour pre revenue - highly speculative biotechs in phase 11 as safe havens
Biotechs with revenues and actual commercialised drugs - like the big billion dollar pharmas
DYOR
- Forums
- ASX - By Stock
- AACR covided
''Biotech, domestic healthcare manufacturing and food staples...
-
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online